期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝移植治疗原发性肝癌的入选标准 被引量：2

下载PDF
导出
摘要 中国是肝癌发病率最高的国家^[1]，肝癌患者在国内恶性肿瘤的死亡率中排第2位^[2]，其中约90％患者合并乙肝肝硬化．目前手术切除是肝癌患者获得长期生存的有效措施，但大部分肝癌患者就诊时已属中、晚期，多伴有严重的肝硬化、肝功能差，能够接受手术切除的不到10％^[3]．此外，
作者 张捷
机构地区 昆明医学院第二附属医院 云南省外科学会 云南省移植学会 云南省肝胆胰研究所 云南省器官移植研究所
出处 《昆明医学院学报》 2012年第1期1-2,124,共3页 Journal of Kunming Medical College
关键词 原发性肝癌 移植治疗 乙肝肝硬化 肝癌患者 标准 手术切除 癌发病率 恶性肿瘤
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献14

  • 1PARKIN D M,BRAY F,FERLAY J,et al.Estimating the world cancer burden:globocan2000[J].International Journal of Cancer,2001,94(2):153-156.
  • 2PARKIN D M,BRAY F,FERLAY J,et al.Global cancer statistics,2002[J].CA:a cancer journal for clinicians,2005,55(2):74-108.
  • 3TANG Z Y,YE S L,LIU Y K,et al.A decade's studies on metastasis of hepatocellular carcinoma[J].Journal of Cancer Research and Clinical Oncology,2004,130(4):187-196.
  • 4PAWARODE A,TANGKIJVANICH P,VORAVUD N.O-utcomes of primary hepatocellular carcinoma treatment:An 8 year experience with 368 patients in Thailand[J].Journal of Gastroenterology and Hepatology,2000,15(8):860-864.
  • 5MAZZAFERRO V,REGALIA E,DOCI R,et al.Liver tr-ansplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J].New England Journal of Medicine,1996,334(11):693-700.
  • 6MAZZAFERRO V,LLOVET J M,MICELI R,et al.Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria:a retrospective,exploratory analysis[J].The Lancet Oncology,2009,10(1):35-43.
  • 7MARSH J W,DVORCHIK I,BONHAM C A,et al.Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?[J].Cancer,2000,88(3):538-543.
  • 8YAO F Y,FERRELL L,BASS N M,et al.Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J].Hepatology,2001,33(6):1 394-1 403.
  • 9HERRERO J I,SANGRO B,QUIROGA J,et al.Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma[J].Liver Transplantation,2001,7(7):631-636.
  • 10BRUIX J,LLOVET J M.Prognostic prediction and treatment strategy in hepatocellular carcinoma[J].Hepatology,2002,35(3):519-524.

二级参考文献30

  • 1严律南,孟宪钦.氧化还原耐受试验对评价肝癌患者肝脏储备功能的价值[J].中华医学杂志,1993,73(3):175-176. 被引量：5
  • 2American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: J B Lippincott, 1998.87-92.
  • 3Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334( 11 ): 693 -699.
  • 4Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 2001,33(6):1394-1403.
  • 5Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer, 2000, 88(3):538-543.
  • 6United Netwerk for Organ Sharing. Liver transplan candidates with hepatocellular carcinoma (HCC). Policy, 2002,3(6):40-44.
  • 7Sharma P, Balan V, Hemandez TL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact.Liver Transpl, 2004, 10(1):36-41.
  • 8Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimerers. Ann Surg, 2002, 235(4):533-539.
  • 9Schwartz M. Liver Transplantation in patients with hepatocellular carcinoma. Liver Transpl, 2004, 10(2):S81-S85.
  • 10Gondolesi G, Munoz L, Matsumoto C, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg, 2002, 6(1):102-107.

共引文献147

同被引文献9

  • 1Paola Tombesi,Francesca Di Vece,Sergio Sartori.Resection vs thermal ablation of small hepatocellular carcinoma:What's the first choice?[J].World Journal of Radiology,2013,5(1):1-4. 被引量：50
  • 2Liu LL, Niemann CU. Intraoperative management of liver trans- plant patients[ J]. Transplant Rev ,2011,25 ( 3 ) : 124-129.
  • 3Devi AS. Transfusion practice in orthotopic liver transplantation [J]. Indian J Crit Care Med,2009,13(3) :120-128.
  • 4Roullet S, Biais M, Millas E, et al. Risk factors for bleeding and transfusion during orthotopic liver transplantation [ J ]. Ann Fr Anesth Reanim,2011,30(4) :349.
  • 5Findlay JY, Fix OK, Pangam - Burtz C, et al. Critical care of the end - stage liver disease patient awaiting liver transplantation [ J ]. Liver Transpl, 2011,17 ( 5 ) :496.
  • 6Sabate A, Dalmau A, Koo M, et al. Coagulopathy management in liver transplantation [ J ]. Transplant Proc, 2012,44 ( 6 ) : 1523- 1525.
  • 7Dasher K,Trotter JF. Intensive care unit management of liver - related coagulation disorders [ J ]. Crit Care Clin, 2012,28 ( 3 ) : 389-398.
  • 8Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease [ J ]. Clin Liver Dis,2009,13 ( 1 ) :21-31.
  • 9Nov - Padillo JA,Le6n - Justel A,Mellado - Miras P,et al. In- troduction of fibrinogen in the treatment of hemostatie disorders during orthotopie liver transplantation : implications in the use of allogenic blood[J]. Transplant Proe,2010,42(8) :2973-2974.

引证文献2

二级引证文献1

昆明医学院学报
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部